MICHAEL LEWIS

Profile

First Name

: MICHAEL

Middle Name

:

Last Name

: LEWIS

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
ACTIVE IMPLANTS CORP
JACK BLAIR, STEPHEN BRADSHAW, THOMAS BUFORD, TROY DREWRY, MICHAEL KEENAN, LARRY KLUGE, LAWRENCE KLUGE, HENRY KLYCE, JAMES LACKIE, DENNIS LONG, MICHAEL MAINELLI, CHARLES MARTIN, WILLIAM MAYS, JR., AMIRAM STEINBERG, RICHARD TREHARNE, NOAM WEISSBERG
DIRECTOR
AEOLUS PHARMACEUTICALS, INC.
KEN BRIGHT, DAVID CAVALIER, DAVID C. CAVALIER, JOHN M. CLERICI, BRIAN DAY, JOHN FARAH, JOHN M. FARAH, JR., MITCHELL D. KAYE, JOSEPH KRIVULKA, JOSEPH J. KRIVULKA, AMIT KUMAR, MICHAEL E. LEWIS, JOHN MCMANUS, JOHN L. MCMANUS, MICHAEL MCMANUS, CHRIS RALLIS, CHRIS A. RALLIS, JEFFREY A. SCOTT, RUSSELL SKIBSTED, PETER SUZDAK, PETER D. SUZKAK
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DAILY INCHES, INC.
NADER AKHNOUKH, LUKE BEATTY, PAUL BELL, CHASE FRASER, CHRIS MARKS, GEORGE MULHERN, THOMAS MURDOCK, TOBY MURDOCK, BRIAN NEIDER, ALI RAHIMTULA, ALEX SHOOTMAN, MARK SOLON, BRIAN WALLACE
DIRECTOR
HISTOGENICS CORP
KIRK ANDRIANO, RASAPPA ARUMUGHAM, JOSHUA BALTZELL, KELLY BECK, BRIAN CALLAHAN, KRISTEN CASTILLO, PRABHAVATHI FERNANDES, PATRICK FORTUNE, DAVID GILL, PETER GREENLEAF, ADAM GRIDLEY, JOHN JOHNSON, JOHN J. JOHNSON, DANIEL JORGENSEN, UDAY B KOMPELLA, GARHENG KONG, GARHENG KONG, M.D., PH.D, GARHENG KONG, M.D., PH.D., RAMESH KUMAR, JONATHAN LIEBER, KEVIN MCARDLE, SHANKAR MUSUNURI, PATRICK O-DONNELL, MANISH POTTI, PHILIP PRESS, KEVIN RAKIN, DOMINIC REDFERN, HARRY REIN, SANJAY SUBRAMANIAN, VIJAY TAMMARA, LAURENCE J.B. TARRANT, SUHA TASPOLATOGLU, JUNGE ZHANG
EXECUTIVE OFFICER
BERENSON CAPITAL PARTNERS, LP
N/A BERENSON ASSOCIATES, LLC, N/A BERENSON MANAGEMENT, LP
EXECUTIVE OFFICER
INSIGHT GLOBAL, LLC
LOU ANDREOZZI, BERT BEAN, MATTHEW CWIERTNIA, JOHN DANHAKL, TIM FLYNN, ROBERT Z. HENSLEY, KEVIN INGHAM, GLENN JOHNSON, IRA D. KLEINMAN, RICHARD LINGLE, DAVID C. LOWANCE, GEORGE D. NELSON, TIM PAYNE, JORDAN SMITH, CHRISTOPHER VOGEL, JAY WILKINS
EXECUTIVE OFFICER
POSY, LLC
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ONWARD CARE, INC.
NADER AKHNOUKH, JEFFREY STOWELL
DIRECTOR
BYE UAS, INC.
GRANT BISHOP, GRANT GRANT BISHOP, JOHN W. BROWN, GEORGE BYE, GEORGE E BYE, GEORGE E. BYE, JAMES S. CHESNUT, JAMES SCOTT CHESNUT, SCOTT CHESNUT, SCOTT CHESTNUT, KIMBERLY GRANT DECASTRO, MARK EIDEMUELLER, MARK A. EIDEMUELLER, NIM EVATT, SUE EVATT, HUGH H FORSYTHE, HUGH H. FORSYTHE, DIANE GARCIA, SANDY GARRETT, RANDY LAUER, MIKE MCGILL, DIANE SIMARD, GEORGE W. TURNER, GREGORY W WALKER, MASON WHITNEY
EXECUTIVE OFFICER
VELOCIS SECONDARY 2020-1, LP
W. FREDERICK HAMM, DAVID E. SEIFERT, PAUL R. SMITH, N/A VELOCIS MANAGEMENT, LLC, N/A VELOCIS SECONDARY 2020-1 GP, LP, N/A VELOCIS SECONDARY UGP, LLC, JAMES E. YODER
EXECUTIVE OFFICER, DIRECTOR
MYCROFT AI INC.
KRIS ADAIR, KRISTIE ADAIR, JOSHUA MONTGOMERY, ROBERT NESS, STEPHEN PENROD, NATE TOMASI
EXECUTIVE OFFICER, DIRECTOR
EJOOV, INC.
TIMOTHY BROWN, CHRISTOPHER HARDING, NEIL HARDING, BRENDAN MANION, ERIC WILLIAMS
PROMOTER
JABEZ BIOSCIENCES, INC.
BRUCE CASSIDY, BRIAN COGLEY, TAMARA JOVONOVICH, MARTIN LEWIS, ROBERT LEWIS, DAVID MEHALICK
PROMOTER
NOK THERAPEUTICS, INC.
BRUCE CASSIDY, BRIAN COGLEY, MARTIN LEWIS, ROBERT LEWIS, DAVID MEHALICK
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-01
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-06-11 
2026-05-01
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-09-24 
2026-04-22
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-08-06 
2026-04-22
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-10-08 
2026-04-22
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-06-27 
2026-03-26
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-06-27 
2026-03-26
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-06-11 
2025-10-28
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-11-11 
2025-10-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-10-08 
2025-10-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-08-06 
2025-10-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-08-07 
2025-10-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2024-11-11 
2022-05-02
D
Link
BUSINESS SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-18 
2021-12-20
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-12-07 
2021-08-11
D
Link
BUSINESS SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-05 
2021-06-11
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-09 
2021-02-01
D
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2020-12-31 
2020-08-12
D
Link
BUSINESS SERVICES 
 
DECLINE TO DISCLOSE 
Debt 
2020-08-06 
2020-04-30
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-20 
2019-04-16
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-13 
2018-05-15
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-10 
2017-01-24
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2017-01-14 
2016-10-12
D
Link
OTHER HEALTH CARE 
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842] 
DECLINE TO DISCLOSE 
Equity 
2016-09-29 
2016-06-16
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2016-06-07 
2015-10-01
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-13 
2014-01-06
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-18 
2013-07-18
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-27 
2013-01-10
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-21 
2012-11-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-20 
2012-07-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-20 
2011-11-21
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-10 
2011-05-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-05-13 
2010-09-20
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-10 
2010-08-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2010-08-11 
2010-08-09
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2009-10-06 
2009-12-02
D/A
Link
OTHER HEALTH CARE 
 
$1,000,001 - $5,000,000 
Equity 
2009-03-13 
2009-11-23
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2009-10-06 
2009-10-09
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2009-10-06 
2009-04-08
D/A
Link
OTHER HEALTH CARE 
 
$1,000,001 - $5,000,000 
Equity 
2009-03-13 
2009-04-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2009-03-30 
2009-03-30
D
Link
OTHER HEALTH CARE 
 
$1,000,001 - $5,000,000 
Equity 
2009-03-13